声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑：小浪快报 第1笔成交价格为51.50元，成交16.00万股，成交金额824.00万元，溢价率为-13.55%，买方营业部为国 泰海通证券股份有限公司杭州学院路证券营业部，卖方营业部为中国银河证券股份有限公司北京苏州街 证券营业部。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为824万元。该股近5个交易日累计下 跌5.40%，主力资金合计净流出2038.53万元。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 1月29日，美迪西收涨1.41%，收盘价为59.57元，发生1笔大宗交易，合计成交量16万股，成交金额824 万元。 ...

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-01-29 | 美迪西 | 688202 | 51.5 824 | 16 | 国泰海通证券股份 有限公司杭州学院 | 中国银河证券股份 有限公司北京苏州 | | 1月29日，美迪西大宗交易成交16万股，成交额824万元，占当日总成交额的3.48%，成交价51.5元，较市场收盘价59.57元折价13.55%。 ...

Market Overview - The medical services sector experienced a decline of 1.41% on January 26, with Meidisi leading the drop [1] - The Shanghai Composite Index closed at 4132.61, down 0.09%, while the Shenzhen Component Index closed at 14316.64, down 0.85% [1] Stock Performance - Notable gainers in the medical services sector included: - Guangzheng Eye Hospital (002524) with a closing price of 5.05, up 10.02% on a trading volume of 266,400 shares and a transaction value of 132 million [1] - Lanwei Medical (301060) closed at 12.28, up 3.98% with a trading volume of 325,000 shares and a transaction value of 392 million [1] - Major decliners included: - Meidisi (688202) closed at 60.88, down 7.28% with a trading volume of 71,600 shares and a transaction value of 444 million [2] - Meinian Health (002044) closed at 7.26, down 6.08% with a trading volume of 3.7675 million shares and a transaction value of 2.776 billion [2] Capital Flow - The medical services sector saw a net outflow of 1.318 billion from institutional investors, while retail investors had a net inflow of 1.011 billion [2] - The capital flow for specific stocks showed: - Boteng Co. (300363) had a net outflow of 39.83 million from institutional investors [3] - Guangzheng Eye Hospital (002524) had a net inflow of 39.29 million from institutional investors [3] - Lanwei Medical (301060) had a net inflow of 24.71 million from institutional investors [3]

Group 1 - Spot gold price has surpassed $5000 per ounce for the first time, with institutions predicting it could rise to $6600 [2] - The recent surge in gold prices is attributed to U.S. President Trump's policies reshaping international relations and investors fleeing sovereign bonds and foreign exchange markets [2] - Last week, gold prices increased by 8.5%, driven by a weakening dollar, which has made gold and silver cheaper for global buyers [2] Group 2 - In the past two weeks, stock ETFs have seen a net outflow of nearly 500 billion yuan, with significant redemptions in broad-based ETFs [3] - The trading volume of stock ETFs has surged, with some broad-based ETFs reaching record highs since their inception [3] Group 3 - The semiconductor sector in A-shares has been active in mergers and acquisitions, with several companies announcing related plans and progress [8] Group 4 - The commercial aerospace sector is experiencing a talent shortage, with investors with relevant experience being highly sought after [9] - The market is facing a significant gap in experienced commercial aerospace investors, leading firms to recruit candidates with adjacent experience [9] Group 5 - Global commodity markets are entering a new super cycle, with fund managers strategically increasing allocations to non-ferrous and chemical products [10] - Factors such as global monetary expansion, a credit crisis in the dollar, and geopolitical conflicts are contributing to this anticipated cycle [10]

Core Viewpoint - The major shareholder of Shanghai Medicilon Inc., Chen Guoxing, has decided to terminate his share reduction plan early, maintaining his current holdings due to confidence in the company's stable development and changes in personal financial needs [3][6]. Shareholder Holdings - Before the reduction plan, Chen Guoxing held 4,875,154 shares, accounting for 3.63% of the total share capital, while his concerted action partner, Lin Changqing, held a total of 8,806,324 shares, representing 6.55% of the total share capital [2][8]. Reduction Plan Implementation Results - On November 20, 2025, Chen Guoxing announced a plan to reduce his holdings by up to 2,200,000 shares (1.64% of total share capital) within three months, but as of the announcement date, he had not executed any reductions and still held 4,875,154 shares [3][6]. - The decision to terminate the reduction plan was based on Chen's confidence in the company's ongoing stability and changes in his financial situation [3][6]. Future Shareholding Intentions - Following the completion of the reduction plan, Lin Changqing intends to continue holding his shares and will consider reducing his holdings based on personal development needs while adhering to relevant laws and commitments [9][10].

（编辑 丛可心） 证券日报网讯 1月25日，美迪西发布公告称，公司股东陈国兴提前终止减持计划，原定2025年12月11日 至2026年3月10日减持不超过2，200，000股（不超过总股本的1.64%），实际未减持，仍持股4，875， 154股，占比3.63%。 ...

同日晚间，美迪西发布公告称，近日公司收到股东陈国兴出具的《关于提前终止减持计划暨减持股份结 果的告知函》，截至公告披露日，股东陈国兴未实施减持，陈国兴基于对公司持续稳定发展的信心以及 自身资金需求的变化，决定提前终止本次减持股份计划，其原计划减持比例不超1.64%。 美迪西表示，截止公告披露日，林长青持有公司股份393.12万股，占公司总股本的2.93%，与其一致行 动人陈国兴合计持有公司股份880.63万股，占公司总股本的6.55%。 北京商报讯（记者 丁宁）1月25日晚间，美迪西（688202）发布股东减持计划公告显示，因股东自身资 金需求，公司股东林长青拟通过集中竞价或大宗交易的方式减持合计不超过所持公司股票80万股，即不 超过0.6%公司股份。 ...

人民财讯1月25日电，美迪西(688202)1月25日公告，公司股东林长青拟15个交易日后的3个月内，通过 集中竞价或大宗交易的方式减持公司股票不超过80万股，即不超过公司总股本的0.60%。 ...

证券代码：688202 证券简称：美迪西 公告编号：2026-002 上海美迪西生物医药股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 截至本公告披露日，上海美迪西生物医药股份有限公司（以下简称"公司"） 股东林长青先生持有公司股份 3,931,170 股，占公司总股本的 2.93%，与其一致 行动人陈国兴先生合计持有公司股份 8,806,324 股股份，占公司总股本的 6.55%。 上述股份来源于公司 IPO 前取得的股份以及公司实施资本公积金转增股本， 林长青的股份已于 2022 年 11 月 7 日起解禁上市流通。 减持计划的主要内容 上述股份减持价格按减持实施时的市场价格确定，符合相关法律法规及上海 证券交易所规则要求；若在减持计划实施期间公司发生派息、送股、资本公积转 增股本、配股等除权除息事项，将根据股本变动对减持数量进行相应调整。 未来持股意向：本次减持计划完成后，股东林长青将继续持有公司股票。林 长青将在严格遵守相关法律法 ...

格隆汇1月25日丨美迪西(688202.SH)公布，因股东自身资金需求，公司股东林长青拟通过集中竞价或大 宗交易的方式减持合计不超过所持公司股票80万股，即不超过公司总股本的0.60%，自减持计划披露之 日起15个交易日后的3个月内（根据中国证监会及上海证券交易所规定禁止减持的期间除外）实施。上 述股份减持价格按减持实施时的市场价格确定。 ...